PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain
Abstract
Authors
T. Dilla P. O'Donohoe J. Möller M. Álvarez J. Sacristán L. San M. Happich A. Tockhorn